证券代码：830879 证券简称：基康技术 公告编号：2025-046 基康技术股份有限公司 第四届监事会第十五次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 8 月 19 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯方式 4.发出监事会会议通知的时间和方式：2025 年 8 月 8 日以邮件方式发出 5.会议主持人：邹勇军先生 6.召开情况合法、合规、合章程性说明： 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律、 法规、部门规章、规范性文件和《公司章程》的有关规定。 （二）会议出席情况 会议应出席监事 3 人，出席监事 3 人。 二、议案审议情况 （一）审议通过《关于取消监事会并修订<公司章程>的议案》 1.议案内容： 根据《中华人民共和国公司法》《上市公司章程指引》《北京证券交易所股 票上市规则》等相关法律法规、规范性文件的规定，结合公司实际情况，公司 不再设置监事会与监 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 8 月 19 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯方式 证券代码：830879 证券简称：基康技术 公告编号：2025-045 基康技术股份有限公司 第四届董事会第十六次会议决议公告 4.发出董事会会议通知的时间和方式：2025 年 8 月 8 日以邮件方式发出 5.会议主持人：董事长袁双红先生 6.会议列席人员：监事、高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律、 法规、部门规章、规范性文件和《公司章程》的有关规定。 （二）会议出席情况 会议应出席董事 9 人，出席董事 9 人。 董事曹洋先生因外出以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于取消监事会并修订<公司章程>的议案》 1.议案内容： 根据《中华人民共和国公司法》《上市公司章程指引》《北京证券交易所股 票上 ...

Investment Rating - The report maintains a positive outlook on the industry, suggesting a focus on high-quality stocks with stable growth and reasonable valuations, particularly in the North Exchange sector for 2025 [6][12]. Core Insights - The North Exchange 50 Index has shown significant growth, with a 116.41% increase over the past year, indicating strong market performance compared to other indices [2][12]. - The report highlights the performance of various sectors, with the computer, basic chemicals, electronics, automotive, and social services sectors leading in growth, while beauty care, defense, construction, agriculture, and textiles lagged behind [17][20]. - New listings and upcoming IPOs are noted, including the recent listing of Zhigao Machinery, which specializes in rock drilling equipment and air compressors, indicating ongoing market activity [25][31]. Summary by Sections North Exchange Market Overview - As of August 15, 2025, the North Exchange comprises 271 A-share stocks with an average market capitalization of 3.183 billion [12]. - The North Exchange 50 Index increased by 2.40% during the week of August 11-15, 2025, closing at 1476.33 points, outperforming the Shanghai and Shenzhen indices [12][16]. Stock and Sector Performance - During the same week, 99 stocks rose, while 170 fell, resulting in a 36.53% increase in the number of rising stocks, a decrease of 15.69 percentage points from the previous week [16]. - The top five performing sectors were computer (21.19%), basic chemicals (8.65%), electronics (6.72%), automotive (3.45%), and social services (2.49%) [17][20]. New Stock Updates - Zhigao Machinery was listed on August 14, 2025, focusing on energy-efficient and environmentally friendly drilling and air compressor solutions, with a diverse product range [25][31]. - Upcoming IPOs include the subscription of Nengzhiguang and the listing of Hongyuan Shares, indicating continued interest in the North Exchange [31]. Key Companies and Earnings Forecast - Key companies highlighted include Tongli Co., Wuxin Tunnel Equipment, and Kaide Quartz, with earnings per share (EPS) forecasts showing growth from 2024 to 2026 [7]. - The report suggests a "Buy" rating for Tongli Co. and Wuxin Tunnel Equipment, while recommending "Hold" for Kaide Quartz and Hualing Co. [7].

Group 1 - Nuclear power is an efficient and clean energy source, with global nuclear power capacity steadily increasing. As of June 2025, China's operational nuclear power units reached 58, with a total capacity of 60.96 million kilowatts, marking the first time it has become the world's largest nuclear power producer [2][8][32] - The nuclear power industry chain includes nuclear fuel cycle, equipment manufacturing, construction, and operation. The upstream involves core and auxiliary equipment manufacturing, engineering management, and nuclear fuel cycle industries. The midstream includes the construction and operation of nuclear power plants, while the downstream focuses on electricity sales to end users [2][8][25] - The market share of nuclear power in China's electricity trading has increased from approximately 30% in 2020 to 46.1% in 2024, indicating a trend towards market-oriented transactions [2][8][32] Group 2 - Recommended companies related to nuclear power on the Beijing Stock Exchange include: 1. Ruichi Intelligent Manufacturing, specializing in high-end process equipment and involved in nuclear energy for over 15 years 2. Klate, the only certified nuclear power fan manufacturer in Shandong Province 3. Tianli Composite, focusing on layered metal composite materials, a rare domestic supplier for nuclear projects 4. Jikang Technology, providing intelligent monitoring solutions for nuclear power plants with experience in major projects 5. Qiuguan Cable, specializing in high and low voltage power cables for nuclear projects 6. Litong Technology, which completed trials for 43 types of nuclear hoses in 2024 and plans project acceptance in 2025 7. Guangsha Environmental Energy, collaborating with Shanghai Nuclear Engineering Research and Design Institute on efficient heat exchangers 8. Changfu Co., a pioneer in domestic nuclear valve actuators, promoting the localization of nuclear valves 9. Gebijia, an innovative company in special functional glass, with some radiation-proof glass products applied in the nuclear industry 10. Qifeng Precision, a high-end fastener technology company working on the localization of nuclear-grade fasteners 11. Kunbo Precision, focusing on precision forming parts and vacuum furnace bodies, expanding nuclear maintenance equipment clients in 2024 [2][8][3] Group 3 - The global nuclear power generation accounted for 9% of total electricity generation in 2024, driven by increasing electricity demand and environmental awareness. Nuclear power is seen as a competitive energy choice, especially for rapidly developing countries lacking traditional fossil fuel resources [2][23][36] - The average utilization hours of nuclear power plants significantly exceed those of other power generation forms, with nuclear plants averaging 7,670 hours in 2023 compared to 3,592 hours for other types [2][24][31]

证券日报网讯8月13日晚间，基康技术发布公告称，公司于2025年8月12日收到国家知识产权局颁发的 《发明专利证书》1项，发明名称为"一种带自补压功能的钻孔应力计"。 ...

证券代码：830879 证券简称：基康技术 公告编号：2025-044 基康技术股份有限公司 （注：本专利申请日为 2025 年 2 月 8 日，当时公司尚未进行全称变更，申 请人名称变更不影响本专利权的归属，公司将依规办理专利权人名称的变更） 基康技术股份有限公司（以下简称"公司"）于 2025 年 8 月 12 日收到国家知 识产权局颁发的《发明专利证书》1 项，具体情况如下： 发明名称：一种带自补压功能的钻孔应力计 专利号：ZL 2025 1 0141004.X 专利权人：基康仪器股份有限公司 授权公告日：2025 年 08 月 12 日 本发明涉及一种带自补压结构的钻孔应力计的结构方案，补压结构包括增压 管、限流筒、活塞、螺纹顶杆及单向阀等结构配件，有效提高了钻孔应力计的安 装便捷性及运行可靠性。 关于公司取得发明专利证书的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、基本情况 二、对公司的影响 上述发明专利证书的取得，进一步体现了公司的科技创新及自主研发能力， 有利于增强公司对知识 ...

Group 1 - The general equipment sector increased by 1.42% on August 11, with Zhejiang Huaye leading the gains [1] - The Shanghai Composite Index closed at 3647.55, up 0.34%, while the Shenzhen Component Index closed at 11291.43, up 1.46% [1] Group 2 - Notable gainers in the general equipment sector included Xiangjiang Nanya, which rose by 10.35% to a closing price of 53.50, and Wande Kai, which increased by 10.12% to 33.19 [1] - Other significant performers included Junmo Co., Da Yuan Pump Industry, and Huanghe Xuanfeng, with respective increases of 10.05%, 10.01%, and 10.00% [1] Group 3 - The general equipment sector experienced a net outflow of 640 million yuan from institutional funds, while retail investors contributed a net inflow of 808 million yuan [2] - The top individual stock performers in terms of trading volume and turnover were highlighted, with Huanghe Xuanfeng achieving a turnover of 1.184 billion yuan [1][2]

Investment Rating - The report does not explicitly provide an investment rating for the industry or specific companies [36]. Core Insights - The aerospace and drone sectors are highlighted as potential catalysts for investment opportunities [3]. - The military industry sector showed significant performance, with notable stock increases for companies like Xingchen Technology (15.9%) and Tongyi Aerospace (7.0%) [3][17]. - The report emphasizes the ongoing interest in innovative pharmaceuticals, AI hardware technology iterations, and new production capabilities, driven by policy benefits and industrial capital [3]. - The North Exchange is expected to strengthen its investment value due to policy-driven and fundamental improvements as more quality companies list on the exchange [3]. Summary by Sections Market Review - On August 4, the North Exchange A-share trading volume reached 19.81 billion yuan, a decrease of 1.92 billion yuan from the previous trading day, with the North Exchange 50 Index closing at 1433.25, up 0.96% [7][15]. - The North Exchange specialized index closed at 2460.21, increasing by 1.42% [7]. Stock Performance - Among the 269 companies on the North Exchange, 158 saw stock price increases, 4 remained flat, and 107 experienced declines [17]. - The top five gainers included Xingchen Technology (15.9%), Tongyi Aerospace (7.0%), and Sanyuan Gene (6.9%) [17][19]. - The top five decliners included Shengtong Valley (-8.5%), Dingjia Precision (-4.9%), and Datang Pharmaceutical (-4.9%) [17][19]. Important News - Significant progress was reported in the development of an AIDS vaccine in China, marking a milestone in the field [20]. - Shanghai's government is promoting the inclusion of more companies in integrated circuits, biomedicine, and artificial intelligence sectors under the "Explorer Program" [21]. Key Company Announcements - Huitong New Materials reported a revenue of 112 million yuan for the first half of 2025, a year-on-year increase of 8.37%, with a net profit of 24 million yuan, up 27.58% [22]. - Guanzhi International announced a revenue of 247 million yuan for the first half of 2025, reflecting a 5.20% year-on-year growth, with a net profit of 46 million yuan, up 7.12% [29].

1. Report Industry Investment Rating - The report maintains an overall optimistic view of the North Exchange market for the whole year, believing that the positioning and development direction of the "specialized, refined, characteristic, and innovative" North Exchange market are highly consistent with the national policy orientation of the "self - controllable" and innovation - driven development strategy [24]. 2. Core Viewpoints of the Report - In July 2025, the North - 50 Index and the North Specialized, Refined, Characteristic, and Innovative Index underperformed major indices such as the ChiNext and STAR Market. However, in the first seven months of 2025, the North - 50 Index rose 37%, outperforming other major indices. The market was weak in July, but some sub - sectors like building decoration and pharmaceutical biology performed well. The market has been in a range - bound consolidation for over two months, and with continuous progress in "high - quality" expansion, code switching of existing stocks, and the issuance of specialized, refined, characteristic, and innovative index funds, the market should gradually turn optimistic. The market may return to the performance - driven mainline, and attention should be paid to high - quality companies with continuous high - growth performance [3][6][24]. 3. Summary by Relevant Catalogs 3.1 Week - view - In July 2025, the North - 50 Index fell 1.68%, and the North Specialized, Refined, Characteristic, and Innovative Index fell 2.70%, underperforming major indices. In the first seven months of 2025, the North - 50 Index rose 37%, far outperforming other major indices, and indices such as the STAR - 200 and CSI 2000 also rose over 20%. In July, sectors such as building decoration and pharmaceutical biology in the North Exchange market had relatively high increases. Only 16 companies had a monthly increase of over 20%, and 6 companies including Hengli Drilling Tools had an increase of over 50%. Compared with June 2025, trading volume, turnover, and turnover rate in July all declined. As of July 31, 2025, the overall price - to - earnings ratio (TTM, excluding negatives) of the North Exchange A - share index reached 51 times, 134% of the ChiNext index and 84% of the STAR Market index [3][6][12]. 3.2 Market Performance - This week, the overall price - to - earnings ratios of the ChiNext, STAR Market, and North Exchange A - shares declined. The North Exchange A - shares' overall PE dropped from 52.17X to 50.92X. In terms of liquidity, the daily average trading volume of North Exchange A - shares this week was 257 billion yuan, a 17% decrease from last week. The daily average turnover rate of North Exchange A - shares dropped to 5.94%, a decrease of 1.1 percentage points from last week. The North - 50 Index fell 2.70% this week, and major indices such as the CSI 300, STAR - 50, and ChiNext also declined [26][27]. 3.3 New Stock Listings - From January 1, 2024, to August 1, 2025, 30 new companies were listed on the North Exchange. From July 28 to August 1, 2025, 1 new company, Dingjia Precision, was listed. From January 1, 2023, to August 1, 2025, the average issue price - to - earnings ratio of 107 listed companies was 16.20X, and the median was 15.86X. The average first - day increase was 111%, and the median was 51% [32][35]. 3.4 New Stock IPOs - From July 28 to August 1, 2025, 2 companies, Aomisen and Sanxie Electric, updated their review status to registration; 1 company, Yangtze River Energy Technology, updated its status to passing the listing committee meeting; 22 companies updated their status to being under inquiry. Next week, the North Exchange will review the IPO applications of 2 companies, Zhongcheng Consulting and Nante Technology [41].

Market Overview - On July 30, the North Exchange A-shares trading volume reached CNY 27.01 billion, an increase of CNY 0.59 billion from the previous trading day[1] - The North Exchange 50 Index closed at 1439.64, down 1.75%, with a PE_TTM of 67.33 times[1] - The North Exchange Specialized and New Index closed at 2459.66, down 1.57%[1] Stock Performance - Out of 268 companies on the North Exchange, 81 rose, 4 remained flat, and 183 fell[1] - The top five gainers were: Yun Chuang Data (28.1%), Ke Li Co. (9.6%), Knight Dairy (9.3%), Fang Yi Pharmaceutical (9.2%), and Da Yu Biological (7.6%)[1] - The top five losers were: Ji Kang Instruments (-12.0%), Wu Xin Tunnel Equipment (-8.7%), Tie Tuo Machinery (-8.1%), Hui Tong New Materials (-7.0%), and Na Ke Nuo Er (-5.7%)[1] Investment Insights - Market focus was on themes such as innovative drugs, AI hardware, and military industry, with notable performance in these sectors[3] - The innovative drug sector showed increased activity due to policy support from the National Medical Insurance Administration[3] - The macro policy direction from the Central Political Bureau meeting supports long-term capital investment in specialized and new enterprises, indicating potential structural opportunities for growth-oriented companies[3] Risk Factors - Potential risks include policy regulatory risks, North Exchange policies falling short of expectations, and intensified industry competition[3]